In contrast, Vilar-Gomez et al. reported that changes in HbA1c, platelets, and ALT normalization better predict the improvement of hepatic fibrosis than APRI, FIB-4 index, and NAFLD fibrosis score [45]. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.